Can Cancer Patients Choose Not to Know the Truth? A New Ethical Debate in Oncology
In this article
The “Right Not to Know” and Information Avoidance in Oncology: Redefining the Principles of Autonomy for the Dynamics of the 21st Century
Information Avoidance: A Modern Phenomenon
Meta-analyses conducted in 2025 and 2026 (Max Planck, 2025) show that approximately 30% of patients reject information about serious health problems through “defensive avoidance.” This is not merely a fear response but an autonomous decision intended to preserve the patient's psychological balance. In oncology, this “defensive avoidance” may hinder a patient's participation in treatment, but the way to overcome this barrier is to strengthen the patient's sense of **“self-efficacy”**, rather than pile on information.
A 2025 UF Health study shows that 93% of cancer patients are exposed to unwanted “misinformation” because of social media algorithms. This pollution increases a patient's tendency to reject “true” information from the physician.
“The Right Not to Know Incidental Findings” (J Med Ethics, 2026) defines not disclosing incidental findings detected during screening without the patient's consent as a new boundary of autonomy.
New Protocols in Oncology Practice:
Current ASCO and MDPI (2025-2026) guidelines recommend not merely telling the truth to patients who “refuse information,” but the strategy of an **“Information Prescription”**. The physician should manage the patient's capacity to receive information through the following stages:
- Identifying the Cognitive Trigger: What should be analyzed is not what the patient knows, but what they are afraid to know (MDPI Practical Guide, 2025).
- Gradual Dosing: Information should be given in “small chunks,” and the patient's emotional response should be observed at each step.
- Representation and Building Trust: For a patient who refuses information, the process of involving a trusted representative in decision-making should be formalized.
Trust and Boundaries in the Digital Age
Discussions of oncology ethics in 2026 emphasize that digitalization is blurring physician-patient boundaries (ASCO Publications, 2024). A patient's refusal of information is sometimes a consequence of distrust of the physician. Being not merely “a messenger carrying the truth” but “a guide who filters information” is the most effective way for a physician to soften a patient's defense mechanisms.
Clinical Wisdom and Empathy
“Although the tumor is our target, the human soul is our refuge. In the oncology world of 2026, truth is not merely a medical datum; it is a healing medicine offered when the patient is ready. A patient's wish 'not to know' is not an escape, but sometimes a way of holding on to life. Our task is not to force that door open, but to wait at the threshold so the patient can enter when ready.”
Current Literature
- • Debrabander, J. (2026). "Autonomy and the Right Not to Know Incidental Findings." Journal of Medical Ethics.
- • MDPI (2025). "Best Practices and Communication Strategies for Informing Oncology Patients." Cancers.
- • Max Planck Institute (2025). "Systematic Review: Medical Information Avoidance Dynamics."
- • ASCO (2024). "Ethics of Patient-Clinician Boundaries in Oncology." ASCO Publications.
- • Neff, P. et al. (2002/2016 Update). "Truth or Consequences." JCO.
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.